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p53N-methyl D-aspartate receptor (NMDA) subunit 2B (NR2B)-containing NMDA receptors and mitochondrial
protein cyclophilin D (CypD) are well characterized in mediating neuronal death after ischemia, respectively.
However, whether and how NR2B and CypD work together in mediating synaptic injury after ischemia remains
elusive. Using an ex vivo ischemia model of oxygen–glucose deprivation (OGD) in hippocampal slices, we
identiﬁed a NR2B-dependent mechanism for CypD translocation onto the mitochondrial inner membrane.
CypD depletion (CypD null mice) prevented OGD-induced impairment in synaptic transmission recovery.
Overexpression of neuronal CypD mice (CypD+) exacerbated OGD-induced loss of synaptic transmission. Inhi-
bition of CypD-dependent mitochondrial permeability transition pore (mPTP) opening by cyclosporine A (CSA)
attenuated ischemia-induced synaptic perturbation in CypD+andnon-transgenic (non-Tg)mice. The treatment
of antioxidant EUK134 to suppress mitochondrial oxidative stress rescued CypD-mediated synaptic dysfunction
following OGD in CypD+ slices. Furthermore, OGD provoked the interaction of CypD with P53, which was en-
hanced in slices overexpressing CypD but was diminished in CypD-null slices. Inhibition of p53 using a speciﬁc
inhibitor of p53 (piﬁthrin-μ) attenuated the CypD/p53 interaction following OGD, alongwith a restored synaptic
transmission in both non-Tg and CypD+ hippocampal slices. Our results indicate that OGD-induced CypD trans-
location potentiates CypD/P53 interaction in a NR2B dependent manner, promoting oxidative stress and loss of
synaptic transmission. We also evaluate a new ex vivo chronic OGD-induced ischemia model for studying the
effect of oxidative stress on synaptic damage.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Many in vivo, in vitro, and human studies have established a role for
glutamate excitotoxicity in neuronal damage after ischemia. Excessive
release of glutamate and overactivation of glutamate receptors
[predominantly N-methyl-D-aspartate (NMDA) receptor] are primarily
responsible for the neuronal death that occurs during ischemic stroke
[2,20,22,25,35]. More speciﬁcally, overactivation of the N-methyl
D-aspartate receptor subunit 2B (NR2B) causes intracellular Ca2+ over-
load and recruits severalmolecules, such as phosphatase and tensin ho-
mologs deleted on chromosome TEN (PTEN) [41] and death-associated
protein kinase 1 (DAPK1) [35] that directly bind to theNMDA receptors,
and nNOS that indirectly couples to the NMDA receptors via PSD95 [4],
leading to neuronal loss [18,19,32,35,41]. Studies on the majority ofD-aspartate; NR2B, N-methyl D-
rivation; mPTP, mitochondrial
ne A; PFT, piﬁthrin-μ (5 μM,NMDA receptor antagonists showed no beneﬁcial efﬁcacy in clinical tri-
als [1,13,16]. It is therefore necessary to study the intracellular players
connecting NMDA receptor activation to neuronal death after ischemia.
In addition to NR2B-containing NMDA receptors and the associated
intracellular signaling pathways, mitochondria play a critical role in
ischemia-mediated neuronal necrosis. It is known that ATP production
withinmitochondria is ceased upon the onset of ischemia, thus neurons
are initially insufﬁciently supply or depleted with energy, leading to
ion hemostasis interruption, massive glutamate release, and NR2B
overactivation [24,31,34]. When mitochondria are reintroduced with
glucose and oxygen during reperfusion, further mitochondria damage
with elevated oxidative stress is elicited [5,7,11], which is harmful for
the recovery of neuronal function after ischemia. Therefore, suppressing
mitochondrial oxidative stress and damage is anticipated to promote
neuronal function recovery.
Cyclophilin D (CypD), a key component ofmitochondrial permeabil-
ity transition pore (MPTP), is located in the matrix under physiology
condition. CypD can be translocated onto mitochondrial inner mem-
brane during pathological insults such as oxidative stress, which trig-
gers the opening of mPTP and elevates reactive oxygen free radicals
(ROS) accumulation in cells [3,8,29]. In ischemia condition, either ge-
netic deletion of CypD or pharmacological inhibition of CypD-
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duces necrosis cell death [3,17,29,30,36]. The most recent studies dem-
onstrated that in response to oxidative stress induced by brain
ischemia/reperfusion injury, p53, a tumor suppressor protein, accumu-
lates in themitochondrialmatrix and triggersmPTP opening and necro-
sis by physical interaction with CypD [15,28,37,42]. However, whether
and how CypD is translocated onto mitochondrial membrane and con-
tributes to functional recoverywhenneurons reintroducedwith glucose
and oxygen remains unknown.
In the present study, using an ex vivo ischemiamodel, OGD, in hippo-
campal slices lacking and gaining neuronal expression of CypD, we
identiﬁed a NR2B-dependent mechanism to trigger CypD translocation
onto the mitochondrial inner membrane, enhancing CypD/p53
interaction and oxidative stress, leading to inhibition of the recovery
of synaptic transmission following OGD. Our results offer new
insight into the role of NR2B-containing NMDA receptors and mito-
chondrial CypD translocation in OGD-induced synaptic dysfunction.
Disassociation of NMDA receptor with mitochondrial CypD transloca-
tion could be a new target for restoring synaptic function upon ischemic
stroke.
2. Materials and methods
2.1. Animals
Protocols involving animal use were approved by the Animal Care
and Use Committee of the University of Kansas-Lawrence in accordance
with the National Institutes of Health guidelines for animal care. CypD
homozygous null mice (CypD−, mice with Ppif−/− depletion) were
kind gifts from Dr. Jeffery D. Molkentin [3]. The offspring of CypD null
mice (termed CypD− mice) were identiﬁed by PCR using primers
[IMR5115: TTCTCACCAGTGCATAGGGCTCTG and IMR5116: GCTTTGTT
ATCCCAGCTGGCGC (reverse)]. To generate transgenic mice overex-
pressing CypD in neurons (termed CypD+ mice) driven by the Thy1-
promoter, we subcloned full length human CypD coding sequences
into a Thy1 transgenic construct. The constructwas veriﬁed by sequenc-
ing. Transgenic founders were backcrossed 10 times into C57BL6/J mice
for analysis of expression patterns. Tgmicewere identiﬁed by PCR using
primers [5′-GCTTTCCCCACCACAGA-3′ (forward) and 5′-TGTTAGGACC
AGCATTAG-3′ (backward)]. Male mice at 3–5 months-old were used
for this study.
2.2. Pharmacological treatment
Drugs were prepared as stock solutions and diluted to the desired
ﬁnal concentration in artiﬁcial cerebral spinal ﬂuid (ACSF) containing:
124 mM NaCl, 4.4 mM KCl, 2 mM CaCl2, 2 mM MgSO4, 1 mM
Na2HPO4, 25 mM NaHCO3, 10 mM D-(+)-glucose or sucrose (for
glucose-free ACSF), immediately before application. Hippocampal slices
with drugs were incubated in recovery or recording subimmerse cham-
bers as needed. The ﬁnal concentrations and sources of the drugs were
as follows: cyclosporin A (CSA; 1 μM, Sigma), Ro 25-6981 (Ro25;
1 μM, Sigma), PPPA (0.5 μM; Tocris), piﬁthrin-μ (PFT; 5 μM, Sigma),
and EUK 134 (EUK; 500 nM, Cayman Chemical). The ﬁnal concentration
of vehicle control ethanol was less than 0.5% in all experiments, which is
the same concentration of ethanol in the solution containing drugs for
the treatment. All reagents were purchased from Sigma (St. Louis,
MO) instead of otherwise stated.
2.3. Slice preparation and oxygen glucose deprivation (OGD)
Animals were decapitated according to the approved protocol and
hippocampi were rapidly removed. Transverse hippocampal slices
(400 μm in thickness) were sectioned as we previously described [12,
40]. All steps were performed in ice-cold oxygenated ACSF solution.
Before recording, hippocampal slices were recovered at 30 °C for 1.5 hin ACSF continuously bubbled with 95% O2 and 5% CO2. During record-
ing, we transferred hippocampal slices into the recording immerse
chamber that wasmaintained at 22± 0.5 °C and perfusedwith oxygen-
ated normal ACSF or 95% N2 and 5% CO2 bubbled glucose-free ACSF for
inducing OGD at a rate of 2.5–3 ml/min. The slice was incubated for an-
other 15–20 min followed by recordings of a stable baseline of synaptic
transmission for 20 min. Field-excitatory post-synaptic potentials
(fEPSPs) were recorded from the CA1 region of the hippocampus by
placing both the stimulating and the recording electrodes in the CA1
stratum radiatum. We assayed the basal synaptic transmission (input–
output curve) by plotting stimulus voltage (V) against slopes of fEPSPs
to generate input–output relations; we then established a 20 min base-
line recording using low-frequency stimulation (0.033 Hz; 0.1 ms im-
pulse duration) and the adjusted intensity that induced fEPSPs with
~50% of themaximal fEPSP amplitude. In experiments using pharmaco-
logical reagents, drugs were continuously perfused over slices starting
5 min before OGD induction and administered for the entire period of
OGD. Values of fEPSP amplitude are expressed asmean± SEM percent-
age change relative to mean baseline amplitude. Reported effects on
synaptic function are equal to synaptic transmission recovery of fEPSPs
calculated as the averaged relative amplitude of fEPSPs with respect to
baseline values after re-introduction of oxygenated normal ACSF (35
to 40 min after the end of OGD).2.4. Mitochondrial isolation and inner membrane fraction preparation
Brain slices were prepared and subjected to OGD with drug treat-
ment as indicated above, and then mitochondria were isolated from
brain slices as described previously [12,26,38]. Samples were placed in
9 ml of ice-cold mitochondria isolation buffer [225 mM mannitol,
75mMsucrose, 2mMK2HPO4 (pH 7.2)], and homogenized (10 strokes)
using aDouce homogenizer (Kontes Glass Co.). Homogenatewas centri-
fuged at 1,300 g for 5 min at 4 °C. The resultant supernatant was then
centrifuged at 34,000 g for 10 min after layering on 15% Percoll. After
centrifugation, the homogenate was resuspended and incubated for
5min on ice in 20ml of mitochondria isolation buffer with 0.02% digito-
nin (Sigma), centrifuged at 8,000 g for 10 min. The pellet was washed
twice in 1.5 ml mitochondria isolation buffer and centrifuged again at
8,000 g for 10 min and the ﬁnal pellets were resuspended in 200 μl mi-
tochondria isolation buffer. Themitochondrial innermembrane fraction
was prepared as described previously [8] and the total protein concen-
tration of isolated mitochondria fraction was determined by protein
assay (Bradford method Bio-Rad Lab).2.5. Co-immunoprecipitation and immunoblotting assays
For immunoprecipitation, hippocampal slices were homogenized in
a non-denaturing lysis buffer containing 50 mM Tris–HCl (pH 7.4),
150 mM NaCl, 1 mM EDTA, 0.5% NP-40 and protease inhibitors (EMD
Millipore, #539137). After centrifugation at 12,000 ×g for 10 min at
4 °C, the supernatant of homogenate or mitochondrial inner membrane
fractions (500 μg) was incubated with an antibody to p53 (Santa Cruz,
#sc-6243) for 16 h at 4 °C and then incubated with protein A/G-
agarose beads (Thermo Scientiﬁc, #20421) for 2 h at 4 °C. Precipitated
complexes were washed in a lysis buffer and bound proteins were ana-
lyzed by immunoblotting. For Western blot experiments, samples were
separated in SDS-PAGE gels, transferred onto membranes, and then
incubated with polyclonal rabbit anti-CypD (generated in our lab) [8],
mouse anti-CypD (Abcam, #ab110324), mouse anti-actin (Sigma,
#2228) ormouse anti-Hsp 60 (Enzo, #ADI-ESP-741) antibody, followed
by anti-rabbit IgG (Life Technologies, #G-21234) or anti-mouse IgG
(Life Technologies, #M-30107) incubation. The density of immunoreac-
tive bands relative to Hsp60 was determined using NIH ImageJ
software.
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Tg CypD+, CypD−, and non-Tg mouse brains were ﬁxed by perfu-
sion with 4% paraformaldehyde and coronal sections (30 μm) were
cut with a Vibratome (Leica VTS1000, Wetzlar Germany). Sections
were collected and immersed in a wash buffer (0.1 M sodium phos-
phate, 0.5 M sodium chloride, 0.1% Triton X-100, pH 7.4) for 1 h. After
preincubation with a blocking solution (10% normal goat serum, 0.3%
Triton X-100 in PBS, pH 7.4) for 1 h at room temperature, sections
were co-immunostained with primary antibodies :mouse anti-CypD
(Ab110324, 1:500; Abcam) and rabbit anti-SODII (1:5000, ADI-SOD-
111, Enzo life Sciences, USA) or rabbit anti-MAP2 (1:500, A16657, Life
Technologies, USA) at 4 °C overnight. Sections were then incubated
with Alexa Fluor 594-conjugated goat anti-rabbit IgG and 488 goat
anti-mouse IgG secondary antibodies (1:1000, Invitrogen) for 1 h at
room temperature. Nucleiwere stained by DRAQ5 (5 μM, Cell Signaling)Fig. 1. Identiﬁcation and characterization of transgenic (Tg) CypD+mice. A) Cyclophilin D (Cy
PCR results. B–C) Immunoblotting of brain homogenates from Tg CypD (lane 2, +) mice a
C) Quantiﬁcation of CypD immunoreactive bands normalized to β-actin. Data are presented as
orescent staining of brain sections for CypD (green) and MAP2 (red) in hippocampus (D) a
blue. F) Quantiﬁcation of CypD staining intensity in hippocampus and cortex regions of the in
(red, mitochondrial marker) and nuclei (blue) in hippocampal and cortical neurons. Scale barfor 10 min at room temperature. The staining images were taken
under confocal microscopy. Brain sections incubated with non-
immune IgG or 2nd antibody alone were used as negative controls. An
investigator who was blinded to experimental groups analyzed all
images. For quantiﬁcation of human CypD staining, brain sections
were randomly selected and measured using MetaMorph software
(Molecular Devices, CA).2.7. Statistical analysis
All data are reported as themean±SEM. Statistical comparisons be-
tween experimental groups or between fEPSP amplitudes measured
during baseline and after the OGD protocol were performed by applying
one-wayANOVA followed by individual post hoc Fisher test. Differences
were considered signiﬁcant when p b 0.05.pD) transgenic mice (+) and non-transgenic (non-Tg,−) control mice were identiﬁed by
nd non-Tg littermate controls (lane 1, −) for CypD, using anti-human CypD antibody.
fold increase relative to non-Tg mice. N = 5–6 mice/group. D–F). The double immunoﬂu-
nd cortex (E) from the indicated Tg mice. Nuclei were stained by DRAQ5 as shown in
dicated Tg mice. G) Representative immunostaining images for CypD (green) and SODII
= 25 μm.
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3.1. Generation and characterization of transgenic mice overexpressing
neuronal CypD
To determine the effect of neuronal CypD, we generated transgenic
(Tg) CypD mice with overexpression of human CypD in neurons
under the control of Thy-1 promoter (Tg CypD+ mice). Tg CypD+
mice were identiﬁed as bearing the transgene from analysis PCR
ampliﬁcation of tail DNA (Fig. 1A). CypD levels were increased by 3–4
fold in brains of Tg CypD+ mice compared with the brains of non-Tg
littermates (Fig. 1B–C) as shown by immunoblotting with speciﬁc anti-
body to CypD [8]. Immunostaining of brain section with CypD antibody
veriﬁed that CypD was increased in cortical and hippocampal neurons
of Tg CypD+ mice but was absent in CypD null mice (CypD−)
(Fig. 1D–E). Consistent with the immunoblotting results, CypD expres-
sion levels were increased by 3–4 fold in neurons of the cortex and hip-
pocampus (Fig. 1F). CypD-positive staining signals were extensively
overlaid with MAP2, a neuronal marker, verifying neuronal expression
of CypD in Tg CypD+ mice. No CypD staining signals were found in
CypD null mice (Fig. 1D–E). Using the double immunoﬂuorescent stain-
ingwith CypD andmitochondrial protein SODII, increased expression of
neuronal CypD in hippocampus and cortex of CypD+mice was identi-
cally co-localized with SODII (Fig. 1G), indicating mitochondrial locali-
zation of CypD in CypD+ mice. CypD null mice were also used for the
study to determinewhether blockade of CypD affords a protective effect
on ischemia-induced synaptic injury.Fig. 2.OGD triggers CypD translocation and inhibition ofmPTP by cyclosporin A (CSA) promotes
CypD levels inmitochondrial inner membrane in the indicated groups of slices. VDAC, CCo andH
mitochondrionmatrix marker, respectively. B) Quantiﬁcation of CypD immunoactive bands rel
ﬁeld-excitatory post-synaptic potentials (fEPSPs) in indicated groups. CSA (1 μM) treatment st
mission recovery of fEPSPs calculated as the averaged relative amplitude of fEPSPs comparedwit
the end of OGD). N = 9 slices from 4–5 male mice (3–4 month-old age) per group.3.2. CypD is a critical molecular target for synaptic transmission recovery
following ischemia
We ﬁrst characterized loss of synaptic transmission during OGD
and synaptic transmission recovery following reintroduction of glu-
cose and oxygen in hippocampal slices. Depending on the incubation
temperature, hippocampal slices showed diminished and irrevers-
ible fEPSPs within minutes at body temperature, but could be a lon-
ger time at hypothermia condition [34]. In the present study, we
aimed to evaluate both protective and deleterious effects on synaptic
transmission recovery after OGD, we thereby ﬁrst explored a condi-
tion in which synaptic transmission can be relatively tolerant to a
longer time of OGD insult and partially recovered after OGD. We re-
corded fEPSPs from the CA1 region of hippocampal slices of non-Tg
mice at different temperatures. Consistent with the previous report
[34], performing OGD experiment at 22± 0.5 °C resulted in tolerance
to 30 min of OGD and that fEPSP amplitude partially recovered and
reached a stable level of depression after glucose and oxygen
reintroduced (34.5 ± 6% of baseline, n= 7 slices). In contrast, we ob-
served a rapid decrease in fEPSP amplitude during 15 min of OGD at
33± 0.5 °C (mean amplitude of the last 3min of OGDwas 1.3± 2% of
baseline, n = 9), and fEPSP amplitude did not recover after 40 min
following reintroduction of oxygenated ACSF (mean relative ampli-
tude of fEPSPs was 9.2 ± 5% of baseline, n = 9) (Data not shown).
Therefore, we assessed the effect of OGD insult at 22 ± 0.5 °C for
30 min duration to assess the effect of CypD on synaptic functional
recovery following OGD.synaptic transmission recovery after OGD. A) Representative immunoblotting bands show
SP60were used as outmembrane ofmitochondria, inner membrane of mitochondria and
ative to CCo in the indicated groups. N= 4mice per group. C) Changes of the amplitude of
arted 5 min before OGD (bar) and presented during entire OGD period. D) Synaptic trans-
h baseline values after re-introduction of oxygenatednormal ACSF (from35 to 40min after
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ischemic insult [15,28,37,42] and that CypD translocation onto the
mitochondrial inner membrane is a critical step for mPTP channel
formation and mitochondrial permeable transition [8,10], we in-
vestigated if OGD triggers CypD translocation from mitochondrial
matrix to the inner membrane, in the non-Tg control animals. Im-
munoblotting of isolated mitochondrial inner membrane fractions
revealed that CypD levels were signiﬁcantly elevated after OGD
when compared with non-OGD control mitochondrial inner mem-
brane fractions (p b 0.05, Fig. 2A, B). To determine if CypD-
mediatedmPTP opening is involved in OGD-induced synaptic trans-
mission deﬁcit, hippocampal slices were treated with cyclosporine
A (CSA, 1 μM), an inhibitor of CypD-dependent mPTP opening.
Treatment with CSA enhanced synaptic transmission recovery
after OGD followed by glucose and oxygen reperfusion (57.6 ± 7%
of baseline, n = 9 slices, p b 0.05 vs vehicle-treated slices; Fig. 2C,
D), suggesting a role for CypD-mediated mPTP in the recovery of
synaptic transmission after OGD.
To evaluate the role of CypD in regulation of synaptic transmission
recovery after OGD, CypD-deﬁcient (CypD−) or CypD-overexpressed
(CypD+) hippocampal slices were subjected to OGD. We found that
loss of synaptic transmission was signiﬁcantly prevented in CypD-
deﬁcient slices (77.9 ± 7%, n = 14 slices) compared with non-Tg slices
insulted by OGD (40.2 ± 10%, n = 9; p b 0.05; Fig. 3A, B). There was a
greater suppression of synaptic transmission recovery (9.3 ± 2%,
n = 10 slices) in CypD-overexpressed slices than non-Tg slices in the
present of OGD (40.2 ± 10%, n = 9; p b 0.05; Fig. 3A, B). Additionally,
CSA treatment abrogated the effect of CypD overexpression on syn-
aptic transmission recovery after OGD (66.2 ± 8%, n = 11; p b 0.05;
Fig. 3C, D). These data demonstrate the involvement of CypD in OGD-
mediated impairment of synaptic transmission.Fig. 3. Effect of CypD on synaptic dysfunction after ischemia. A) Cyclophilin D (CypD) overexpre
cose deprivation (OGD), respectively. B) Summary of theﬁeld-excitatory post-synaptic potentia
mPTP by cyclosporin A (CSA) during OGD signiﬁcantly preserved synaptic transmission in CypD
eraged relative amplitude of fEPSPs compared with baseline values after re-introduction of ox
(from 35 to 40 min after the end of OGD) in indicated groups. N = 8–14 slices from 4–5 male3.3. NR2B activation potentiates OGD-induced CypD translocation
Since NR2B activation exacerbates neuronal injury, we sought to
determine whether OGD-induced CypD translocation required NR2B
activation in non-Tg control animals. Consistent with previous reports,
the phosphorylation level of NR2B at ser1303 was signiﬁcantly
increased upon OGD (Fig. 4A, B), suggesting that the overactivation
of NR2B-containing NMDA receptors exists in our experimental
conditions. Blockade of NR2B (Fig. 4C, E) signiﬁcantly prevented OGD-
induced CypD translocation. Accordingly, less CypD protein was found
in OGD-induced mitochondrial matrix fraction compared with
vehicle-treated control (Fig. 4D), indicating that more CypD protein
was translocated from matrix to the inner membrane. Recordings of
fEPSPs from non-OGD control slices treated with NR2B inhibitor, Ro
25-6981 (1 μM), or the NR2A inhibitor PPPA (0.5 μM), showed a non-
signiﬁcant reduction in fEPSP amplitude (Fig. 4F, G). However, NR2B in-
activation preserved synaptic transmission but not NR2A inhibitor
treatment after OGD (Fig. 4H, I), suggesting the speciﬁc effect of NR2B
inhibition on OGD-induced synaptic impairment. Our data indicate
that the CypD translocation via OGD-induced NR2B activation is, at
least in part, responsible for the damage of synaptic transmission recov-
ery after OGD.
3.4. CypD/p53 interaction and related oxidative stress are required for
synaptic dysfunction in ischemia
Given that CypD/p53 interaction elicits mPTP opening and oxidative
stress, leading to ischemia-induced cell death [15,28,37,42], we next
sought to investigate whether CypD/p53 interaction is responsible for
OGD-induced deﬁcit in synaptic transmission recovery among non-Tg,
CypD− and CypD+mice. We determined the effect of NR2B on CypD/ssion suppresses and CypDdeﬁciency restores synaptic transmission after oxygen and glu-
l (fEPSP) recovery during the last 5min of OGD in indicated groups. C) Inhibition of CypD−
overexpressed animals. D) Synaptic transmission recovery of fEPSPs calculated as the av-
ygenated normal artiﬁcial cerebrospinal ﬂuid (ACSF, see Materials and methods section)
mice per group.
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dure for hippocampal homogenates. As previously reported, CypD
formed a complex with p53 in OGD-induced slices compared with
vehicle-treated non-Tg slices (Fig. 5A). CypD+ slices signiﬁcantly
increased OGD-induced CypD/p53 complex formation compared
with non-Tg slices (Fig. 5A). No CypD/p53 complex was found in
CypD− slices either before or after OGD (Fig. 5A). These data indicate
a protective effect of CypD depletion onOGD-induced synaptic dysfunc-
tion. Accordingly, increased CypD expression exacerbates synaptic per-
turbation induced by OGD-mediated ischemia, possibly via OGD-
induced elevation of CypD/p53 complex formation.
We next tested if inhibition of p53 by perfusion of non-Tg slices with
piﬁthrin-μ (PFT), an inhibitor of p53, affects interaction of CypD with
p53. Administration of piﬁthrin-μ to non-Tg hippocampal slice blocked
CypD/p53 complex formation as seen in co-immunoprecipitation assay
for brain mitochondria (Fig. 5B), suggesting the involvement of p53
activation in OGD-induced CypD/p53 interaction.
Given that NR2B activation was necessary for CypD translocation
andwas critical for OGD-induced synaptic dysfunction, we next investi-
gated if inactivation of NR2B suppresses mitochondrial CypD/p53Fig. 4.N-methyl D-aspartate receptor subunit 2B (NR2B) activation is involved in OGD-induced
ting bands (A) and quantiﬁcation of (B) show the phosphorylation level of NR2B at ser1303 in
chondrial inner membrane fraction andmatrix (D) in indicated groups. E) Quantiﬁcation of Cyp
mice per group. F) No signiﬁcant changes in synaptic transmission were found in nonTg slices p
1 µM) under normal condition. G) Average of the last 5min of reperfusion fEPSP amplitude in th
injury after OGD. I) Synaptic transmission recovery of ﬁeld-excitatory post-synaptic potentials
values after re-introduction of oxygenated normal artiﬁcial cerebrospinal ﬂuid (ACSF, see Ma
from 4–5 male mice (3–4 month-old age) per group.interaction after OGD. As shown in Fig. 5C, treatment with NR2B inhib-
itor Ro 25-6981 but not NR2A inhibitor PPPA blocked OGD-induced
CypD/p53 complex formation in non-Tgmice. Therewere no signiﬁcant
effects of both inhibitors (R0 25-6981 and PPPA) on the CypD/p53 inter-
action in non-Tg slices without OGD. These results suggest that activa-
tion of NR2B-containing glutamate receptors is required for OGD-
induced CypD/p53 interaction, which in turn regulates synaptic trans-
mission recovery after OGD.
To further evaluate the direct role of p53 in synaptic transmission
following OGD, we measured fEPSPs recovery from non-Tg and CypD-
overexpressed hippocampuswith orwithout treatment of p53 inhibitor
piﬁthrin-μ (PFT). The perfusion of PFT (1 μM) in non-Tg slices did not af-
fect synaptic transmission in the absence of OGD (p N 0.05; Fig. 6A, B),
whereas treatment with PFT maintained a synaptic transmission after
OGD comparedwith vehicle-treated slices (p b 0.05; Fig. 6A, B).We fur-
ther demonstrated that synaptic depression was signiﬁcantly restored
in CypD+ slices with the continuous perfusion of PFT compared with
CypD+ vehicle treated slices after OGD/reperfusion (p b 0.05; Fig. 6C,
D). Treatment of PFT to CypD− hippocampal slice failed to show further
beneﬁcial effects on synaptic transmission after OGD (data not show).cyclophilin D (CypD) translocation and synaptic injury. A–B) Representative immunoblot-
indicated groups. C–D) Representative immunoblotting bands show CypD levels in mito-
D immunoreactive bands normalized to CCo in indicated groups shown in panel C. N= 4
erfused with NR2A (PPPA, 0.5 µM) compared with those treated with NR2B (Ro 25-6981,
e indicated groups. H) Inhibition of NR2B but not NR2A signiﬁcantly ameliorated synaptic
(fEPSPs) calculated as the averaged relative amplitude of fEPSPs compared with baseline
terials and methods section) (from 35 to 40 min after the end of OGD). N = 6–10 slices
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tion protects against synaptic depression after OGD insult even under
conditions of increased CypD expression. Taken together with the pro-
tective effect of lacking CypD in OGD-mediated perturbation, these re-
sults suggest that CypD/p53 interaction followed by NR2B activation
contributes to OGD-impaired synaptic transmission recovery.
CypD/p53 complex formation is involved in the generation of mito-
chondrial oxidative stress [15,28,37,42]. We next examined if antioxi-
dant treatment would promote synaptic transmission recovery after
OGD. We tested the effect of antioxidant EUK134 on fEPSP recovery
after OGD (Fig. 6E, F). When slices overexpressing CypD were continu-
ously perfused with antioxidant EUK 134 (500 nM), we observed a sig-
niﬁcant rescue of synaptic transmission after OGD (86.3 ± 4%, n = 8
slices; p b 0.05 vs. vehicle treated slices after OGD; Fig. 6E, F). The pro-
tective effect of EUK134 perfusion was not due to modulation of
NR2B-containing receptor activation since it didn't affect pSer1303
NR2B after OGD (Data not shown). Thus, CypD/p53-mediated oxidative
stress is involved in synaptic depression in ischemia.
4. Discussion
A large body of studies has established that activation of NR2B
and the associated intracellular signaling pathways are responsible
for ischemic stroke-induced synaptic injury and neuronal loss. An in-
creasing number of evidence also suggests that mitochondria are im-
portant for ischemia-induced neuronal death. Here we provide the
ﬁrst piece of evidence, showing that NR2B activation actually
works together with mitochondrial CypD and suppresses theFig. 5. The effect of p53 and NR2B activation on OGD-induced CypD/p53 complex formation in
followed by immunoblotting with CypD antibody revealed CypD immunoreactive bands at 5
was elevated in CypD-overexpressed mice and absent in CypD-deﬁcient animals. β-Actin ban
Piﬁthrin-μ (PFT, 5 μM) treatment signiﬁcantly suppressed OGD-induced CypD/p53 interactio
CypD/p53 interaction from the isolated brain mitochondria after OGD. Experiments repeated arecovery of synaptic transmission upon OGD. Our results suggest
OGD-induced CypD translocation onto mitochondrial membrane de-
pendent on NR2B activation. Additionally, OGD-induced CypD trans-
location facilitates CypD/p53 complex formation and enhances
oxidative stress, which is responsible for the loss of synaptic
transmission.
Our current data illustrated a new ﬁnding that OGD induced CypD
translocation onto membrane via a NR2B-dependent mechanism.
CypD is one of the key regulatory components of mPTP and plays a
vital role in a number of disorders, including Alzheimer's disease (AD)
[8–10], diabetes [14,23,38] and ischemia [27–29,37]. Inhibition of
CypD activity and blockade of mPTP opening reduces infarct size after
ischemia/reperfusion [30]. Studies in genetically CypD-deﬁcient mice
provided direct evidence for the role of CypD in mediating mPTP open-
ing, oxidative stress and subsequent necrotic cell death after cerebral or
cardiac ischemia/reperfusion [27,29,37]. However, whether and how
CypD translocates onto mitochondrial membrane under OGD insults is
notwell understood. In the present study,weﬁrst detected an increased
CypD level in the inner membrane of mitochondria subjected to OGD,
suggesting that OGD-induced CypD translocationmay underline the en-
hanced mPTP opening leading to mitochondrial oxidative stress and
synaptic dysfunction. Indeed, inhibition of mPTP by perfusion of phar-
macological inhibitor CSA ameliorated loss of synaptic transmission
and increased synaptic recovery. Similar protective effects on OGD-
induced synaptic failure were obtained from genetic depletion of
CypD. Furthermore, overexpression of neuronal CypD exacerbated the
synaptic transmission loss after OGD. We also demonstrated that
OGD-induced NR2B activation is necessary for CypD translocationnon-Tg mice. A) Immunoprecipitation of hippocampal homogenates with p53 antibody
3 kD in OGD-exposed non-transgenic (non-Tg) hippocampal tissue. CypD/p53 complex
ds show the equal amounts of protein used for Co-immunoprecipitation experiments. B).
n in mitochondrial fractions. C) Inactivation of NR2B subunit instead of NR2A prevented
t least 3 times; 5–6 mice per group. PFT: piﬁthrin-μ; Ro25: Ro25-6981.
2232 Z. Zhang et al. / Biochimica et Biophysica Acta 1852 (2015) 2225–2234based on the observation that blockade of NR2B suppressed CypD trans-
location onto the innermembrane ofmitochondria. In parallel, blockade
of NR2B but not NR2A activation in OGD protects against OGD-induced
insufﬁcient recovery of synaptic transmission.
While it is well known that glutamate mediates excitatory synaptic
transmission in the brain and accelerates synaptic degeneration in a
number of neuronal disorders including ischemic stroke [2,20,22,25],
the mechanisms underlying NR2B-driven CypD translocation onto
membrane have not been elucidated yet. As to our knowledge, extracel-
lular glutamate levels rise abruptly in ischemia, thereby resulting in
over-activation of NR2B-containing NMDAR at extrasynaptic sites. Acti-
vated NR2B subunits directly interact with PTEN [41] or DAPK1 [35], or
indirectly associate with nNOS via PSD95 [4], subsequently modulate
downstream signaling pathways such as calpain, p25, striatal-enriched
protein tyrosine phosphatase (STEP), p38, JNK, PKC and sterol regulato-
ry element binding protein-1 (SREBP1) for excitotoxic neuronal death
[6,21,32,33,39]. Activation of NR2A-containingNMDA receptors via syn-
aptic transmission leads to activation of the prosurvival signaling pro-
teins Akt, ERK, and CREB [19,39]. Similar to what was previously
reported, blockade of NR2B instead of NR2A has a protective effect on
synaptic transmission recovery after ischemia. More interestingly, our
results suggest that activation of NR2B underlies OGD-induced CypD
translocation onto the inner membrane of mitochondria, oxidative
stress and deﬁcits in synaptic transmission recovery. This study certain-
ly adds new insights into the body of glutamate toxicity relevant to is-
chemia, which is a connection of NR2B activation to CypD-mediated
synaptic injury upon OGD. Thus, blockade of NR2B activation byFig. 6. Suppression of CypD/p53 complex formation via blockade of p53 or antioxidant EUK134p
inhibitor, piﬁthrin-μ (PFT, 5 μM), perfusion (dash line) of non-transgenic (non-Tg) slices did not
ever, it signiﬁcantly promoted synaptic transmission recovery after OGD (solid bar). B) Synapt
compared with baseline values after re-introduction of oxygenated normal artiﬁcial cerebro
pretreated with p53 inhibitor preserved synaptic transmission after OGD. E–F) The antioxidant
mission in CypD+ slices. N = 6–10 slices from 4–5 male mice (3–4 month-old age) per groupinterception of NR2B with CypD interaction could hold a potential ther-
apeutic strategy for ischemia-induced synaptic and neuronal damage.
Our results also indicated that CypD/p53 complex might not only
cause cell death but alsomediate the functional deﬁcit of synaptic trans-
mission recovery after OGD. P53 was recently reported to be rapidly
translocated to mitochondria and to form CypD/p53 complex following
ischemic insult, which results in mPTP opening and oxidative stress,
leading to cell death in vivo and in vitro [28,37]. Indeed, we observed
NR2B activation-dependent mitochondrial translocation of CypD,
which promoted CypD/p53 complex formation after OGD. The CypD/
p53 interactionwasmodulated byCypD expression level, and in parallel
the synaptic transmission recovery was associated with CypD expres-
sion. Similarly, inhibition of p53 by its inhibitor PFT during OGD signif-
icantly suppressed CypD/p53 interaction as well as promoted synaptic
transmission recovery. These results suggest that CypD/p53 interaction
contributes to synaptic transmission deﬁcit in OGD. Furthermore,
inhibition of CypD-dependent mPTP opening by CSA, or suppression
of mitochondrial oxidative stress by administration of antioxidant
EUK134 abolished impairment in OGD-insulted synaptic transmission
in CypD-overexpressed slices in which CypD/p53 interaction was aug-
mented after OGD.
It is noted that our experiments were performed in ex vivo condi-
tions, and therefore the further studies using in vivo ischemic stroke
model would be favorable. In addition, some of the OGD studies, includ-
ing the present one, were carried out at room temperature condition in
which hippocampal slice ismore tolerant to a long timeOGD insult [34].
The observed events might not fully stand in in vivo conditions. Givenerfusionmaintained synaptic function after oxygen and glucose deprivation (OGD). A) p53
change ﬁeld-excitatory post-synaptic potentials (fEPSPs) under baseline conditions. How-
ic transmission recovery of fEPSPs calculated as the averaged relative amplitude of fEPSPs
spinal ﬂuid (from 35 to 40 min after the end of OGD). C–D) CypD-overexpressed slices
EUK134 pretreatment (0.5 μM) abolishes the deleterious effect of OGD on synaptic trans-
.
2233Z. Zhang et al. / Biochimica et Biophysica Acta 1852 (2015) 2225–2234that hypothermia is the most beneﬁcial and operative method in clinic
for neuronal protection, the results generated in hypothermia condition
are more closed to clinical implication. In this study, we performed our
in vitro ischemic experiments at room temperature condition.We dem-
onstrated that inhibiting oxidative stress either by CAS or EUK134 treat-
mentwas beneﬁcial for synaptic transmission after OGD. Therefore, this
novel ex vivo ischemiamousemodel may be more appropriate to study
oxidative damage rather than excitotoxic damage in ischemic condition.
Additionally, NR2B-mediated CypD translocation might be only part of
the mechanisms for the deﬁcits of synaptic transmission recovery
after OGD. Our current investigation did not distinguish the effects of
NR2B-mediated CypD translocation on the severity of OGDdamage dur-
ing glucose and oxygen deprivation period from the direct effects on re-
covery processes when glucose and oxygen were reintroduced to
hippocampal slices.
In summary, using an ex vivo ischemia model on slices of CypD null
mice, mice overexpressing neuronal CypD and non-Tg littermates, we
clearly demonstrate that NR2B activation promotes CypD translocation
along with CypD/p53 interaction following OGD-induced ischemia. The
absence of CypD or inhibition of p53 completely abolishes CypD/p53 in-
teraction and improves synaptic transmission recovery after OGD. The
possible underlying mechanism of OGD-induced synaptic injury is
that NR2B activation drives CypD translocation to the mitochondrial
inner membrane where CypD interacts with P53, promoting oxidative
stress, eventually leading to synaptic dysfunction after OGD. Thus,
disassociating NR2B activation and mitochondrial CypD membrane
translocation might promote synaptic transmission recovery after
OGD. Advanced understanding of the mitochondrial mechanism for
ischemia-induced synaptic injury such as those shown here will help
develop new potential therapeutic strategies to prevent brain damage
after brain ischemia.
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